What Stryker's FY2025 10-K says: 12 signals
Stryker filed its latest 10-K with the SEC on Feb 11, 2026. It discusses compliance burden, acquisition completed and capacity constraint.
Public (SYK)Medical Equipment Manufacturing10,000+ employeesstryker.comLinkedIn
- Filed
- Feb 11, 2026
- Period
- FY2025
- Fiscal year end
- 12/31
- Filings
- 1
10-K · latest 10
What Stryker's 10-K filings say
- SEC EDGAR
10-K · FY2025
Filed · Fiscal year ends 12/31 · 12 signals
Stryker faces multi-year compliance costs for European Union MDR regulation through December 2028.
The company must comply with the European Union's stringent Medical Device Regulation (MDR) by a December 2028 deadline, a complex and costly process.
The company is actively investing to counter evolving cybersecurity threats, including those from generative AI, and to comply with new, stricter regulations on incident disclosure.
information technology (IT)cloudsoftware-as-a-serviceopen-source software
Acknowledges security risks from legacy third-party software components in IT systems
The company identifies that some of its IT systems rely on legacy software, creating potential security vulnerabilities that their current 'layered security approach' may not effectively mitigate.
Unable to meet customer demand due to supply chain issues, resulting in lost sales
The company explicitly states that supply chain problems have prevented it from fulfilling all customer orders, directly causing a loss of revenue.
Stryker completed the acquisition of Inari in 2025 to expand its technology portfolio.
The acquisition of Inari is part of a stated strategy to invest in new products and technologies.
Acknowledging ongoing security breaches and emerging threats from generative AI, Stryker is actively investing in its security technology platform, including AI monitoring and expert hiring.
ITcloudsoftware-as-a-serviceopen-source software
The company acknowledges a competitive risk from rivals who may more quickly adopt emerging technologies like AI and machine learning.
roboticsartificial intelligence (AI)machine learningconnectivity solutions
Stryker faces significant pricing pressure from China's volume-based procurement process.
Government cost-containment initiatives, specifically China's volume-based procurement for medical devices, are creating intense pricing pressure.
Stryker reports lost sales due to sole-source supplier disruptions and supply chain challenges.
Reliance on sole-source suppliers for raw materials and components has previously led to product unavailability and lost sales.
The recent acquisition of Inari in 2025 presents significant integration risks, including potential for a slower-than-projected timeline and diversion of management focus.
Inari
Showing 10 of 12 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Stryker with the Signal API
One POST /v1/companies/enrich call with stryker.com returns Stryker 10-K signals (sec-10k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"stryker.com","signal_types":["sec-10k"],"limit":20}'Same industry
10-K at related companies
Questions about Stryker 10-K
When did Stryker file its latest 10-K?
What does Stryker's latest 10-K say about compliance burden?
Where can I find Stryker's annual report?
Source. Annual reports (Form 10-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .